Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designation
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received
Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to
Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.
India's WiproLab45 unveiled its Decentralized Identity and Credential Exchange (DICE) ID to put the user in control of their medical data, approval to
A large study provides clues on how long immunity lasts against Covid reinfection and does vaccination help in reducing its severity
About 1.5 million are homeless in Turkey after the largest earthquake disaster devastated the country, with 210 million tonnes of rubble awaiting clearance,
Zydus Lifesciences, a subsidiary of Zydus Pharmaceuticals US, has received two tentative FDA approvals, one for treating type 2 diabetes and the other
Apellis Pharmaceuticals, a US-based biopharmaceutical company, has got FDA approval for a drug to treat geographic atrophy, the company announced.
Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.
Glenmark Pharmaceuticals, a US-based company, has received a tentative second FDA approval for its oral drug to treat high blood pressure.